Anika Therapeutics, Inc. ANIK
13.23 USD -0.05 (-0.38%)
Regular-session close
13.23 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
12.98 Day range 13.70
9.13 52-week range 22.03
- YTD
- +37.67%
- 1 year
- +42.26%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 112.82M | 119.91M | 120.79M | 113.83M | 147.79M | |
| 63.81M | 76.00M | 82.53M | 73.22M | 82.94M | |
| -11.05M | -5.10M | 844.00K | 3.67M | -18.48M | |
| -10.88M | -56.38M | -82.67M | -14.86M | 4.13M | |
| -0.76 | -3.83 | -5.64 | -1.02 | 0.28 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 57.48M | 55.63M | 68.74M | 86.33M | 94.39M | |
| 190.27M | 202.74M | 270.63M | 349.13M | 347.54M | |
| 46.80M | 48.75M | 58.37M | 63.56M | 60.45M | |
| 24.20M | 24.01M | 25.91M | 28.82M | 19.24M | |
| 143.47M | 153.99M | 212.26M | 285.56M | 287.08M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 11.19M | 5.40M | -1.79M | 4.41M | 8.40M | |
| -401.00K | -8.33M | -5.43M | -7.49M | -3.12M | |
| -10.55M | -12.73M | -6.32M | -4.85M | -6.78M | |
| -6.83M | -8.33M | -5.43M | -7.49M | -5.14M | |
| 322.00K | -15.71M | -13.46M | -8.06M | -1.43M |
